Eli Lilly teams with antibody upstart AbCellera in coronavirus hunt
As the Covid-19 outbreak reaches official pandemic levels and begins to disrupt US life in unprecedented ways, Eli Lilly is joining the hunt for a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.